Correlation Between Processa Pharmaceuticals and Third Harmonic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Third Harmonic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Third Harmonic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Processa Pharmaceuticals and Third Harmonic Bio, you can compare the effects of market volatilities on Processa Pharmaceuticals and Third Harmonic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Third Harmonic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Third Harmonic.

Diversification Opportunities for Processa Pharmaceuticals and Third Harmonic

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Processa and Third is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Third Harmonic Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Third Harmonic Bio and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Third Harmonic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Third Harmonic Bio has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Third Harmonic go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Third Harmonic

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to under-perform the Third Harmonic. But the stock apears to be less risky and, when comparing its historical volatility, Processa Pharmaceuticals is 1.12 times less risky than Third Harmonic. The stock trades about -0.16 of its potential returns per unit of risk. The Third Harmonic Bio is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  1,350  in Third Harmonic Bio on August 28, 2024 and sell it today you would lose (106.00) from holding Third Harmonic Bio or give up 7.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy97.67%
ValuesDaily Returns

Processa Pharmaceuticals  vs.  Third Harmonic Bio

 Performance 
       Timeline  
Processa Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Third Harmonic Bio 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Third Harmonic Bio are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Third Harmonic may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Processa Pharmaceuticals and Third Harmonic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Processa Pharmaceuticals and Third Harmonic

The main advantage of trading using opposite Processa Pharmaceuticals and Third Harmonic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Third Harmonic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Third Harmonic will offset losses from the drop in Third Harmonic's long position.
The idea behind Processa Pharmaceuticals and Third Harmonic Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators